Skip to main navigation Skip to search Skip to main content

Induction of B cell tumor dormancy by anti-idiotypic antibodies

  • Eitan Yefenof*
  • , Louis J. Picker
  • , Richard H. Scheuermann
  • , Ellen S. Vitetta
  • , Nancy E. Street
  • , Thomas F. Tucker
  • , Jonathan W. Uhr
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Long-term dormancy of murine B-cell lymphomas can be experimentally induced by immunizing the host with the idiotype expressed on the tumor. Interaction of the cells with anti-idiotype antibodies is sufficient to induce and maintain the dormant state. The growth of lymphoma cells interacting with anti-idiotype antibodies is arrested and they undergo dramatic changes in their morphology, cell-cycle status and oncogene expression. Regrowth of a tumor after long-term dormancy results from the emergence of a tumor cell variant that no longer responds to the antibodies with growth inhibition. These data demonstrate the feasibility of reversing a malignant phenotype of cells by specific growth arrest signals and suggest new approaches for therapeutic intervention in cancer.

Original languageEnglish
Pages (from-to)740-744
Number of pages5
JournalCurrent Opinion in Immunology
Volume5
Issue number5
DOIs
StatePublished - Oct 1993

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Induction of B cell tumor dormancy by anti-idiotypic antibodies'. Together they form a unique fingerprint.

Cite this